Market open · Delayed intraday data · 11:59 AM ET
Last update: Nov 17, 2026, 11:32 AM ET
Medtronic Plc
$102.97▲ 0.09% today
Market Open

Why Medtronic Plc (MDT) stock moved

No significant move on Nov 16, 2026 (+0.0%, close-to-close). Latest notable session: Nov 4, 2026.

Latest session▲ 6.1% · Nov 4, 2026 close

Why Medtronic plc (MDT) rose 6.1% on November 4, 2026

Medtronic plc (MDT) rose 6.1% on November 4, 2026, closing at $104.96 versus $98.88 the prior session (close-to-close, from daily closes). Following completion of its MiniMed Split-Off and share retirement program, which retired approximately 55 million shares through an oversubscribed exchange offer without cash outlay (247wallst.com, Yahoo Finance). The move adds ~$6 billion to market value and structurally reduces share count to boost future EPS while refocusing the company on higher-margin core medical device business. Source: 247wallst.com.

Updated
Prior close
$98.88
Nov 4, 2026 close
$104.96
Change (close-to-close)
+$6.08
+6.15%
As first detected · Nov 4, 2026, 12:12 PM ET

Medtronic surged +6.24% to $105.05 following completion of its MiniMed Split-Off and share retirement program, which retired approximately 55 million shares through an oversubscribed exchange offer without cash outlay (247wallst.com, Yahoo Finance). The move adds ~$6 billion to market value and structurally reduces share count to boost future EPS while refocusing the company on higher-margin core medical device business. Volume of 5.4M shares ran at 0.47x the expected pace for this point in the session, suggesting concentrated participation.

What to watch next: Medtronic earnings on November 17, 2026 (consensus EPS estimate $1.33); any post-separation guidance or commentary on organic growth trajectories and margin expansion.

Source: 247wallst.com · percentages in this note are as captured at detection; the confirmed close-to-close move is shown above.

Earlier sessions that moved MDT

  1. +2.8%Driven by positive real-world clinical data for its cardiovascular portfolio—including strong results from the Sphere-9 catheter and PulseSelect Pulsed Field Ablation systems—combined with completion of the MiniMed separation and retirement of approximately 55 million shares, which boosts future EPS (Motley Fool, Nov.
  2. +3.8%Medtronic announced positive real-world registry results for its Sphere-9™ catheter and PulseSelect™ PFA System at the APHRS 2026 conference (PR Newswire), driving a +2.72% intraday gain to $95.56.
  3. +3.9%Medtronic's stock-for-stock exchange offer for MiniMed Group was oversubscribed based on preliminary results.
  4. +2.6%Driven by a Barclays upgrade to Hold and announcement of the final exchange ratio (4.5939) for the MiniMed Group, Inc. split-off ahead of the October 9 offer expiration, per the web catalyst.
  5. −2.7%Medtronic PLC (MDT) shares are trading lower today, down -2.20% to $87.53 in late morning trading.The primary catalysts driving the downward pressure include: - Ex-Dividend Date Adjustments : Medtronic's recently declared dividend of $0.72 per share had its ex-dividend date set for September 25.

Medtronic Plc (MDT) shares rose 0.1% to $102.97 as of November 17, 2026, a slight gain from the prior close of $102.88. BestStocks flagged the session as a material change for MDT. The move is tied to company news. Below, we break down what changed for MDT, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

Company News

Medtronic announced acquisition of Contego Medical to expand carotid artery disease treatment portfolio. Acquisition strengthens MDT's position in vascular intervention market and adds next-generation carotid therapies.

This summary describes the catalyst and move as first detected on Nov 16, 2026, 10:19 AM EST; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
NewsWeak confidence
Rel. volume
0.1×
Below Avg
Vs peers
—
No comparable peers
Market cap
$131.7B
New York Stock Exchange
Analyst target
$101
-2.2% vs price
Price chart
Oct 19 – Nov 17
NVNVVNF$93$99$105Oct 19Oct 26Nov 3Nov 10Nov 17
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Medtronic Plc investors

For Medtronic Plc investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.1% session move; Positive price momentum. Weighing against that: Medtronic plc (MDT) moved -5.11% from $83.57 to $79.30 on 2026-07-14; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $100.69, implying -2.2% downside from $102.97. BestStocks rates the overall signal quality weak (19/100). With earnings roughly 7 days out, the next report is the most likely near-term test of the move.

MDT price reaction

MDT last traded at $102.97, up $0.09 (+0.09%) from the previous close of $102.88. The session traded on 0.1× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $92.77 and $104.96, and it currently sits about 84% of the way up that band.

Bullish and bearish analyst opinions on Medtronic Plc (MDT)

The consensus analyst price target on Medtronic Plc (MDT) is $100.69, 2.2% below the recent $102.97. Over the past 90 days analysts logged 0 upgrades, 13 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MDT line up.

The bullish case

  • The Street's most bullish target is $120.00 (+16.5%).
  • Positive 0.1% session move.
  • Positive price momentum.
  • Medtronic plc (MDT) moved +5.04% from $79.20 to $83.19 on 2026-07-02.

The bearish case

  • The consensus analyst price target of $100.69 sits 2.2% below the recent $102.97, so the average target sees limited room to run.
  • The most bearish analyst target is $83.00 (-19.4%).
  • Medtronic plc (MDT) moved -5.11% from $83.57 to $79.30 on 2026-07-14.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Nov 17, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $101-2.2%
= 13 maintains
BTIG maintained Buy · 2026-10-12
SEC filings watch
8-K2026-10-19
Material event — review for impact
high
8-K2026-09-17
Material event — review for impact
high
10-Q2026-09-03
Quarterly financial results
medium
8-K2026-09-01
Material event — review for impact
high
Peer context
MDT+0.1%

Previous notable changes for MDT

Valuation2026-11-04+6.1%via 247wallst.com ↗
Medtronic surged +6.24% to $105.05 following completion of its MiniMed Split-Off and share retirement program, which retired approximately 55 million shares through an oversubscribed exchange offer without cash outlay (247wallst.com, Yahoo Finance). The move adds ~$6 billion to market value and structurally reduces share count to boost future EPS while refocusing the company on higher-margin core medical device business. Volume of 5.4M shares ran at 0.47x the expected pace for this point in the session, suggesting concentrated participation.
News2026-11-04+6.1%
Medtronic will report Q2 FY2027 financial results on November 24, 2026.
Activity2026-11-02+2.8%via fool.com ↗
Medtronic rose 2.27% to $98.73, driven by positive real-world clinical data for its cardiovascular portfolio—including strong results from the Sphere-9 catheter and PulseSelect Pulsed Field Ablation systems—combined with completion of the MiniMed separation and retirement of approximately 55 million shares, which boosts future EPS (Motley Fool, Nov. 2). Volume of 2.4M shares ran below historical average for this stage of the session.
Activity2026-10-22+3.8%via PR Newswire ↗
Medtronic announced positive real-world registry results for its Sphere-9™ catheter and PulseSelect™ PFA System at the APHRS 2026 conference (PR Newswire), driving a +2.72% intraday gain to $95.56. Volume remains below average at 0.24x expected levels for this time of session, suggesting limited participation in the move so far.

In-depth MDT event analyses

Permanent, dated analyses of MDT's most significant sessions.
Upcoming catalysts & outlook
Next earnings
2026-11-24 (est.)
in 7 days
10-Q Filing (est.)
2026-12-03
Medium impact
Thesis shift
Neutral / Mixed
bullish signal
Risk level
Medium
from change events

Frequently asked questions about MDT

Why did Medtronic Plc (MDT) stock move?

Medtronic plc (MDT) rose 6.1% on November 4, 2026, closing at $104.96 versus $98.88 the prior session (close-to-close, from daily closes). Following completion of its MiniMed Split-Off and share retirement program, which retired approximately 55 million shares through an oversubscribed exchange offer without cash outlay (247wallst.com, Yahoo Finance). The move adds ~$6 billion to market value and structurally reduces share count to boost future EPS while refocusing the company on higher-margin core medical device business. Source: 247wallst.com.

How much did MDT stock rise?

MDT gained 0.09% ($0.09) versus the prior close of $102.88, last trading at $102.97 on 0.1× average volume.

When is Medtronic Plc's next earnings date?

MDT's next earnings report is estimated for 2026-11-24 — about 7 days away.

What is the analyst price target for MDT?

The consensus analyst price target for MDT is $100.69, about 2.2% below the current $102.97. Over the past 90 days, analysts recorded 0 upgrades, 13 maintains, and 0 downgrades.

How BestStocks tracks MDT

This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for MDT, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 17, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataCompany news feedsSEC EDGAR filingsAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.